Oarsman Capital, Inc. Abbott Laboratories Transaction History

Oarsman Capital, Inc.

$533 Million
Q3 2024

A detailed history of Oarsman Capital, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Oarsman Capital, Inc. holds 5,475 shares of ABT stock, worth $641,286. This represents 0.12% of its overall portfolio holdings.

Number of Shares

5,475

Previous 5,604 2.3%

Holding current value

$641,286

Previous $582,000 7.22%

% of portfolio

0.12%

Previous 0.13%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$100.07 - $118.13 $12,909 - $15,238	-129 Reduced 2.3%	5,475 $624,000
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $106,874 - $119,298	1,061 Added 23.35%	5,604 $582,000
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $447,279 - $494,000	-4,084 Reduced 47.34%	4,543 $516,000
Q4 2023 Feb 16, 2024	BUY	$90.19 - $110.4 $32,919 - $40,296	365 Added 4.42%	8,627 $949,000
Q3 2023 Oct 27, 2023	SELL	$95.53 - $114.62 $1,432 - $1,719	-15 Reduced 0.18%	8,262 $800,000
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $7,155 - $7,972	-71 Reduced 0.85%	8,277 $902,000
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $58,116 - $68,406	600 Added 7.74%	8,348 $845,000
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $33,175 - $38,920	-349 Reduced 4.31%	7,748 $850,000
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $70,428 - $85,125	-690 Reduced 7.85%	8,097 $880,000
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $82,664 - $100,804	725 Added 8.99%	8,787 $1.04 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $86,647 - $106,095	-750 Reduced 8.51%	8,062 $1.14 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $12,132 - $13,422	-104 Reduced 1.17%	8,812 $1.04 Million
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $68,133 - $80,271	-626 Reduced 6.56%	8,916 $1.07 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $253,575 - $276,324	-2,415 Reduced 20.2%	9,542 $1.05 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $9,530 - $11,574	-104 Reduced 0.86%	11,957 $1.3 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $645,408 - $826,042	8,429 Added 232.08%	12,061 $1.1 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $550,680 - $805,244	-8,766 Reduced 70.7%	3,632 $287,000
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $4,867 - $5,418	-62 Reduced 0.5%	12,398 $1.08 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $4,010 - $4,348	-49 Reduced 0.39%	12,460 $1.04 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $145 - $170	-2 Reduced 0.02%	12,509 $1.05 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $19,799 - $23,937	-299 Reduced 2.33%	12,511 $1 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $131,644 - $149,134	2,008 Added 18.59%	12,810 $927,000
Q3 2018 Nov 07, 2018	SELL	$60.81 - $73.36 $17,999 - $21,714	-296 Reduced 2.67%	10,802 $792,000
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $13,528 - $14,931	-235 Reduced 2.07%	11,098 $677,000
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $19,413 - $21,948	-345 Reduced 2.95%	11,333 $679,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $561,244 - $626,407	11,678	11,678 $623,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oarsman Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oarsman Capital, Inc. with notifications on news.

Account

Oarsman Capital, Inc. Abbott Laboratories Transaction History